The reduction in KPC tumor growth with suppression of Plgrkt or S100a10 expression in the tumor cell is consistent with low tumor expression of these genes in human PDAC being associated with prolonged patient survival (see Fig. S2A,B). The gene discussed is S100A10; the disease is neoplasm.